Sponsor

Nuvaira, Inc.

Clinical research sponsor

Published trials7
Recruiting shown1
Roles1
SourceClinicalTrials.gov

Clinical trials

7 shown
Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPDNCT07051707 · lead sponsor · 2026-02-24
RECRUITING
Evaluation of the Safety and Efficacy of TLD in Patients with COPDNCT03639051 · lead sponsor · 2019-05-23
ACTIVE_NOT_RECRUITING
Evaluating the Safety and Feasibility of TLD for the Treatment of Severe AsthmaNCT02872298 · lead sponsor · 2017-12-22
TERMINATED
Discovery of the Impact of Targeted Lung Denervation (TLD) on the Severe and Very Severe COPD PopulationNCT03213080 · lead sponsor · 2017-12-01
WITHDRAWN
Targeted Lung Denervation for Patients With Moderate to Severe COPDNCT02058459 · lead sponsor · 2014-08-04
COMPLETED
Evaluation of the IPS System for TLD Therapy in Patients With COPDNCT01716598 · lead sponsor · 2012-10-01
COMPLETED
Innovative Pulmonary Solutions (IPS) System for Targeted Lung DenervationNCT01483534 · lead sponsor · 2011-10-01
COMPLETED

Sponsor roles

lead sponsor7

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.